Fate of US abortion drug hangs in balance ahead of Friday deadline

Mifepristone will lose its FDA approval this week unless an appeals court intervenes in a case likely to reach the supreme court

FDA authorization for a key abortion drug could be nullified after Friday, unless an appeals court acts on a Biden administration request to block last week’s ruling suspending approval of the drug.

The drug, mifepristone, is used in more than half of all the abortions in the US. The ruling, issued by a federal judge in Texas, applies across the country.